1. Home
  2. EFOI vs CMMB Comparison

EFOI vs CMMB Comparison

Compare EFOI & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFOI

Energy Focus Inc.

N/A

Current Price

$2.84

Market Cap

21.0M

ML Signal

N/A

Logo Chemomab Therapeutics Ltd.

CMMB

Chemomab Therapeutics Ltd.

HOLD

Current Price

$2.60

Market Cap

19.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
CMMB
Founded
1985
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
19.9M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
EFOI
CMMB
Price
$2.84
$2.60
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
5.4K
104.2K
Earning Date
05-12-2026
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
43.75
101.67
EPS
N/A
0.04
Revenue
$3,560,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$67.25
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$1.35
52 Week High
$9.84
$3.55

Technical Indicators

Market Signals
Indicator
EFOI
CMMB
Relative Strength Index (RSI) 46.90 65.37
Support Level $2.83 $1.49
Resistance Level $3.00 $2.86
Average True Range (ATR) 0.15 0.22
MACD 0.00 -0.00
Stochastic Oscillator 44.83 62.13

Price Performance

Historical Comparison
EFOI
CMMB

About EFOI Energy Focus Inc.

Energy Focus Inc specializes in designing, developing, manufacturing, and selling energy-efficient lighting systems and controls. It provides LED lighting solutions for both commercial and military maritime markets (MMM). Its core products include robust lighting fixtures and lamps for navy and military applications, Energy Storage Systems (ESS), Uninterruptible Power Supply (UPS), and tubular LED (TLED) lighting products, including battery backup units as well as general commercial and maritime lighting fixtures. The company operates in a single business segment that includes the marketing and sale of commercial and MMM lighting products and controls. The company generates a majority of its revenue from the sales of military maritime products in the United States.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Share on Social Networks: